Year: 2025

Regeneron Reports Third Quarter 2025 Financial and Operating Results

Written by Customer Service on October 28, 2025. Posted in Earnings Releases And Operating Results.

Third quarter 2025 revenues increased 1% to $3.75 billion versus third quarter 2024 Dupixent® global net sales (recorded by Sanofi) increased 27% to $4.86 billion EYLEA HD® U.S. net sales increased 10% to $431 million; total EYLEA HD and EYLEA® U.S. net sales decreased 28% to $1.11 billion GAAP EPS of $13.62 and non-GAAP EPS(a) of $11.83; third quarter 2025 includes unfavorable $0.68 impact from acquired IPR&D charge FDA approved Libtayo® as the first and only immunotherapy for high-risk adjuvant cutaneous squamous cell carcinoma (CSCC); EMA’s CHMP adopted positive opinion Positive Phase 3 results reported from trials in generalized myasthenia gravis, fibrodysplasia ossificans progressiva (FOP), and cat and birch allergies; updated positive data reported from pivotal trial in children with profound genetic hearing lossTARRYTOWN,...

Onity Group Schedules Conference Call – Third Quarter 2025 Results and Business Update

Written by Customer Service on October 28, 2025. Posted in Public Companies.

WEST PALM BEACH, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) — Onity Group Inc. (NYSE: ONIT) (“Onity” or the “Company”) today announced that it will hold a conference call on Thursday, November 6, 2025 at 8:30 a.m. (ET) to review the Company’s third quarter 2025 operating results and provide a business update. All interested parties are welcome to participate. You can access the conference call by dialing (833) 316-1983 or (785) 838-9310 approximately 10 minutes prior to the call; please reference the conference ID “Onity.” Participants can also access the conference call through a live audio webcast available from the Shareholder Relations page at onitygroup.com under Events and Presentations. An investor presentation will accompany the conference call and be available by visiting the Shareholder Relations page at onitygroup.com prior...

ESPAS and Steinehelden Use Descartes’ Solution to Optimize Ecommerce Productivity by 500% While Supporting Special Needs of Workers

Written by Customer Service on October 28, 2025. Posted in Public Companies.

LEIPZIG, Germany and ATLANTA, Oct. 28, 2025 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Switzerland’s ESPAS, a non-profit foundation for labor integration that manages ecommerce fulfillment for various web shops, and Germany’s Steinehelden, a non-profit company that operates an online shop for LEGO® products, are using Descartes’ ecommerce warehouse management system (WMS) to optimize ecommerce fulfillment processes, reduce error rates and increase customer satisfaction. With its user-friendly interface and the ability to tailor workflows to the needs of employees, the solution is also supporting the integration of persons with and without disabilities into the workforce. “Our employees are people who face barriers in...

Orion Group Interim Report January–September 2025

Written by Customer Service on October 28, 2025. Posted in Earnings Releases And Operating Results.

ORION CORPORATION INTERIM REPORT 1–9/2025 28 OCTOBER 2025 at 12:00 EET Orion Group Interim Report January–September 2025 July–September 2025 HighlightsNet sales totalled EUR 423.2 (July–September 2024: 471.3) million Operating profit was EUR 121.0 (202.0) million Net sales and operating profit of the comparison period include EUR 130 million of major milestone payments Basic earnings per share were EUR 0.68 (1.14) Cash flow from operating activities per share was EUR 0.55 (0.48) The outlook for 2025 has been specified: Net sales are estimated to be EUR 1,640 million to EUR 1,720 million. Operating profit is estimated to be EUR 410 million to EUR 490 million. Previously net sales were estimated to be EUR 1,630 million to EUR 1,730 million and operating profit was estimated to be EUR 400 million to EUR 500 million.January–September...

Provident Financial Holdings Reports First Quarter of Fiscal 2026 Results

Written by Customer Service on October 28, 2025. Posted in Earnings Releases And Operating Results.

Net Income of $1.68 million in the September 2025 Quarter, Up 3% from the Sequential Quarter and Down 12% from the Comparable Quarter Last Year Net Interest Margin of 3.00% in the September 2025 Quarter, Up Six Basis Points from the Sequential Quarter and Up 16 Basis Points from the Comparable Quarter Last Year Loans Held for Investment of $1.04 Billion at September 30, 2025, Down Slightly from $1.05 Billion at June 30, 2025 Total Deposits of $874.8 Million at September 30, 2025, Down 2% from June 30, 2025 Non-Performing Assets to Total Assets Ratio of 0.15% at September 30, 2025, Up from 0.11% at June 30, 2025 RIVERSIDE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Provident Financial Holdings, Inc. (“Company”), NASDAQ GS: PROV, the holding company for Provident Savings Bank, F.S.B. (“Bank”), today announced earnings for the first...

Axalta Releases Third Quarter 2025 Results

Written by Customer Service on October 28, 2025. Posted in Earnings Releases And Operating Results.

PHILADELPHIA, Oct. 28, 2025 (GLOBE NEWSWIRE) — Axalta Coating Systems Ltd. (NYSE:AXTA) (“Axalta”), a leading global coatings company, announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights:Third quarter net sales of approximately $1.3 billion Net income of $110 million with a net income margin of 8.5%, an increase of 80 basis points year over year Record quarter for Adjusted EBITDA of $294 million Adjusted EBITDA margin expanded 70 basis points year over year to 22.8% Diluted EPS increased 11% to $0.51 Record quarter for Adjusted Diluted EPS of $0.67, an increase of 6% Executed $100 million in share repurchases“We executed another strong quarter delivering record Adjusted EBITDA and Adjusted Diluted EPS. Our results reflect our focus on operational excellence while the...

Check Point Software Reports 2025 Third Quarter Financial Results

Written by Customer Service on October 28, 2025. Posted in Earnings Releases And Operating Results.

Strong Demand Drives 20 Percent Calculated Billings Growth Year Over Year TEL AVIV, Israel, Oct. 28, 2025 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), today announced its financial results for the quarter ended September 30th, 2025. Third Quarter 2025 Financial Highlights:Calculated Billings*: $672 million, a 20 percent increase year over year Total Revenues: $678 million, a 7 percent increase year over year Security Subscriptions Revenues: $305 million, a 10 percent increase year over year GAAP Operating Income: $199 million, representing 29 percent of total revenues Non-GAAP Operating Income: $282 million, representing 42 percent of total revenues GAAP EPS**: $3.28, a 79 percent increase year over year Non-GAAP EPS**: $3.94, a 75 percent increase year over year“Check Point delivered strong third...

onsemi’s Treo Platform Selected by Teledyne for Advanced Infrared Imaging Design

Written by Customer Service on October 28, 2025. Posted in Public Companies.

Treo’s ROIC process technology leverages high-density, low-power architecture for mission-critical aerospace, defense, security, and scientific applications SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) — onsemi today announced that Teledyne Technologies has selected its Treo platform to develop next-generation readout integrated circuit (ROIC) application-specific integrated circuits (ASICs) for infrared imaging systems. As the industry’s most advanced analog and mixed-signal platform, Treo can be combined with specialized ROIC modules to meet the demands of infrared focal plane array (FPA) systems, which are essential to a wide range of aerospace, defense, security, and scientific applications. Built on an advanced 65nm node, the Treo platform features a modular architecture and a rich set of IP building blocks that help...

Karolinska Development invests SEK 7.5 million to support BOOST Pharma’s continued development of BT-101 towards Phase 3

Written by Customer Service on October 28, 2025. Posted in Public Companies.

Stockholm, Sweden – October 28, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that it has exercised its pro rata participation of SEK 7.5 million in BOOST Pharma’s latest financing. In total, BOOST Pharma’s financing, structured as a convertible loan, brings SEK 15 million to the company. The investment supports the continued preparation for Phase III clinical development of BT-101, a pioneering stem cell-based therapy for osteogenesis imperfecta (OI), also known as brittle bone disease. BOOST Pharma, a clinical-stage biopharmaceutical company, is advancing BT-101 as a novel mesenchymal stem cell therapy for infants born with osteogenesis imperfecta (OI) , a condition characterized by fragile bones, frequent fractures and bone deformity. The treatment is designed to reduce fracture frequency in affected pediatric...

Upgrade of guidance

Written by Customer Service on October 28, 2025. Posted in Public Companies.

ANNOUNCEMENT NO. 295 28 October 2025Upgrade of guidance ChemoMetec experiences an increased interest in its technology, not the least the XcytoMatic platform, and consequently expects a positive trend in revenue and profit particularly in the last part of the financial year 2025/26. Consequently, revenue in the financial year 2025/26 is now expected to be DKK 565-580 million against the most recently announced DKK 545-565 million, while EBITDA is expected to be in the range of DKK 320-335 million compared to the most recently announced DKK 295-315 million. ChemoMetec’s trading statement for Q1 2025/26 is expected to be published on 6 November 2025.Additional information Martin Helbo Behrens, CEOTel.: (+45) 48 13 10 20 Kim Nicolajsen, CFOTel.: (+45) 48 13 10 20 About ChemoMetec A/S ChemoMetec develops, manufactures and markets...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals